Catalent
CTLT
#1496
Rank
S$15.61 B
Marketcap
$86.02
Share price
0.00%
Change (1 day)
47.72%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

EPS for Catalent (CTLT)

EPS in 2023 (TTM): -$1.72

According to Catalent's latest financial reports the company's current EPS (TTM) is -$1.75. In 2022 the company made an earnings per share (EPS) of $3.08 a decrease over its 2021 EPS that were of $4.43.

EPS history for Catalent from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.72-155.94%
2022$3.08-30.58%
2021$4.4379.67%
2020$2.47114.12%
2019$1.15-15%
2018$1.3675.44%
2017$0.77-22.97%
2016$1.00-59.56%
2015$2.48282.05%
2014$0.65-378.2%
2013-$0.23

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$1.07-161.24%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.02-41.86%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.91 9.30%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
$8.66-595.35%๐Ÿ‡บ๐Ÿ‡ธ USA